Polymer-coating represents a key component of drug-eluting stent (DES) technology and its possible impact on vessel-wall healing is a matter of debate. The clinical impact of different polymer-coating may be assessed by comparing the outcome of patients treated by DES having the same stent platform and drug, and differing in the polymer. Thus, we compared the clinical outcome of patients treated by Endeavor Zotarolimus-eluting stent (E-ZES) and Resolute Zotarolimus-eluting stent (R-ZES) as they differ in the polymer-coating only.
Talarico, G. P., Burzotta, F., Trani, C., Tommasino, A., Niccoli, G., Porto, I., Leone, A. M., Mongiardo, R., Schiavoni, G., Crea, F., One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology, <<CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS>>, 2013; 81 (2): 268-273. [doi:10.1002/ccd.24498] [http://hdl.handle.net/10807/41467]
One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology
Talarico, Giovanni Paolo;Burzotta, Francesco;Trani, Carlo;Tommasino, Antonella;Niccoli, Giampaolo;Porto, Italo;Leone, Antonio Maria;Mongiardo, Rocco;Schiavoni, Giovanni;Crea, Filippo
2013
Abstract
Polymer-coating represents a key component of drug-eluting stent (DES) technology and its possible impact on vessel-wall healing is a matter of debate. The clinical impact of different polymer-coating may be assessed by comparing the outcome of patients treated by DES having the same stent platform and drug, and differing in the polymer. Thus, we compared the clinical outcome of patients treated by Endeavor Zotarolimus-eluting stent (E-ZES) and Resolute Zotarolimus-eluting stent (R-ZES) as they differ in the polymer-coating only.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
